Clinical trial
Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis
NCT00287430 · University of Texas Southwestern Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00287430 |
|---|---|
| Title | Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | Dana S Hardin |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug, Procedure |
| Interventions | Growth Hormone, Whole body Protein Turnover Study, Dual Energy X-ray Absorptiometry (DEXA) |
| Enrollment | 0 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Feb 6, 2006 |
| Last update posted | Mar 12, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: